Biolexis Therapeutics, Inc.
PrivateLast Round
Seed Round
May 20, 2026
Total Funding Raised
$13.98M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biolexis Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in American Fork, Utah. Its latest recorded funding round was a Series A round in November 2023.
Biolexis Therapeutics, Inc. is a biotechnology company that utilizes a proprietary AI-enabled platform for the discovery and development of small molecule therapeutics for metabolic, inflammatory, and other chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biolexis Therapeutics, Inc. Comparables
Compare Biolexis Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ambrosia Biosciences Inc. | 83% | |
| Syntis Bio, Inc. | 82% | |
| Verdiva Bio | 81% |
For institutional investors. Book with your work email.
Biolexis Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 20, 2026 | ||||
| Series A | Nov 22, 2023 | ||||
| Seed | Oct 3, 2023 | ||||
| Seed | Sep 2, 2022 | ||||
| Debt | Feb 14, 2022 |
For institutional investors. Book with your work email.
Biolexis Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Clarke Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 427% MoM, from 280 to 1.5K.
- May 20, 2026
$1.6M raised in Seed Round funding.
For institutional investors. Book with your work email.
Biolexis Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biolexis Therapeutics, Inc.'s valuation, stock price, and market status.
Is Biolexis Therapeutics, Inc. a public or private company?
Biolexis Therapeutics, Inc. is a private company.
What is the current stock price of Biolexis Therapeutics, Inc.?
Biolexis Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Biolexis Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biolexis Therapeutics, Inc. worth (valuation)?
Valuation information for Biolexis Therapeutics, Inc. is not publicly available.
Can I buy Biolexis Therapeutics, Inc. stock?
Biolexis Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biolexis Therapeutics, Inc.'s last funding round?
Biolexis Therapeutics, Inc.'s most recent funding round was Seed Round on May 20, 2026.
Who are the main investors in Biolexis Therapeutics, Inc.?
Key investors in Biolexis Therapeutics, Inc. include Clarke Capital Partners.
Will Biolexis Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Biolexis Therapeutics, Inc..
How can I track Biolexis Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Biolexis Therapeutics, Inc.'s shares on secondary markets.